|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Covidien |
|---|---|
| Information provided by: | Covidien |
| ClinicalTrials.gov Identifier: | NCT00998374 |
Purpose
This study will compare glucose and simple carbohydrate sensitivity. The hypothesis is that rapid emptying of high-glycemic index foods after Roux-En-Y gastric bypass (RYGB) causes reactive hypoglycemia. It is believed that the controlled release offered by an intact pylorus will be advantageous for long term results in bariatric surgery. This study can provide a scientific rationale, in a short duration of time, for why pylorus sparing surgery, such as the sleeve gastrectomy or duodenal switch, may offer therapeutic advantages, as compared to non-pyloric sparing surgery, namely the gastric bypass.
| Condition |
|---|
|
Hypoglycemia Obesity |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge |
| Estimated Enrollment: | 60 |
| Study Start Date: | September 2009 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Pyloric-sparing group vs. non-pyloric sparing group
Pylorus sparing = sleeve gastrectomy and duodenal switch procedures Non-pylorus sparing = gastric bypass procedure |
Clinical Trial Objective:
The objective of this clinical trial is to determine whether an intact pylorus prevents reactive hypoglycemia following challenge with liquid glucose preparation and/or solid load made of refined flour product that is a simple carbohydrate.
Clinical Trial Design:
This is a prospective, non-randomized, clinical trial.
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Patients >18 years of age BMI greater than or equal to 35
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: JoAnne Weiskopf, RPA-C | 212-434-3285 | jweiskopf@lenoxhill.net |
| Contact: Yuriy Dudiy | 718-501-0284 | ydudiy@lenoxhill.net |
| United States, New York | |
| Lenox Hill Hospital 186 E76th Street, 1st Floor | Recruiting |
| New York City, New York, United States, 10021 | |
| Principal Investigator: | Mitchell Roslin, MD | Lenox Hill Hospital |
More Information
| Responsible Party: | Mitchell Roslin, MD, Lenox Hill Hospital |
| ClinicalTrials.gov Identifier: | NCT00998374 History of Changes |
| Other Study ID Numbers: | AS08018 |
| Study First Received: | October 15, 2009 |
| Last Updated: | April 5, 2011 |
| Health Authority: | United States: Institutional Review Board |
|
Hypoglycemia Obesity Glucose Metabolism Disorders Metabolic Diseases Overnutrition |
Nutrition Disorders Overweight Body Weight Signs and Symptoms |